GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Cyclically Adjusted PS Ratio

Laurus Labs (BOM:540222) Cyclically Adjusted PS Ratio : 7.48 (As of Jun. 03, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Laurus Labs's current share price is ₹611.35. Laurus Labs's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar25 was ₹81.74. Laurus Labs's Cyclically Adjusted PS Ratio for today is 7.48.

The historical rank and industry rank for Laurus Labs's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:540222' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.39   Med: 5.87   Max: 7.67
Current: 7.45

During the past 12 years, Laurus Labs's highest Cyclically Adjusted PS Ratio was 7.67. The lowest was 4.39. And the median was 5.87.

BOM:540222's Cyclically Adjusted PS Ratio is ranked worse than
88.35% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs BOM:540222: 7.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Laurus Labs's adjusted revenue per share data of for the fiscal year that ended in Mar25 was ₹102.920. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹81.74 for the trailing ten years ended in Mar25.

Shiller PE for Stocks: The True Measure of Stock Valuation


Laurus Labs Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Laurus Labs's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Cyclically Adjusted PS Ratio Chart

Laurus Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.39 5.29 7.51

Laurus Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.29 - - - 7.51

Competitive Comparison of Laurus Labs's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Cyclically Adjusted PS Ratio falls into.


;
;

Laurus Labs Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Laurus Labs's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=611.35/81.74
=7.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laurus Labs's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar25 is calculated as:

For example, Laurus Labs's adjusted Revenue per Share data for the fiscal year that ended in Mar25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar25 (Change)*Current CPI (Mar25)
=102.92/157.5517*157.5517
=102.920

Current CPI (Mar25) = 157.5517.

Laurus Labs Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201603 35.380 102.518 54.373
201703 40.978 105.196 61.373
201803 37.559 109.786 53.900
201903 42.061 118.202 56.063
202003 51.712 124.705 65.333
202103 87.772 131.771 104.945
202203 90.668 138.822 102.901
202303 111.457 146.865 119.568
202403 93.250 153.035 96.003
202503 102.920 157.552 102.920

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Laurus Labs  (BOM:540222) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Laurus Labs Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines